Rapporten

Dybdegående analyser af virksomhedsfinansiering, vækststrategier og markedsindsigt fra verdens mest innovative virksomheder

196 rapporter og tæller

Opdateret dagligt med den seneste markedsintelligens
Fundraising
Beam Therapeutics

Beam Therapeutics Raises $206M in Series C

Beam Therapeutics, a Biotech company based in 238 Main Street, Cambridge, MA 02142, has raised $206M in Series C at a $3.5B valuation led by Foresite Capital, F-Prime Capital, Omega Funds, Redmile Group, Wellington Management.

Fundraising News Team
May 3, 2024
0 min read
Biotech
Beam Therapeutics

Beam Therapeutics raises $206M Series C at $3.5B valuation

Beam Therapeutics raises $206M in Series C at $3.5B valuation. Base editing technology...

Editorial Team
May 3, 2024
0 min read$206M
Biotechnology
Beam Therapeutics

Beam Therapeutics Headquarters - Office Location & Address

Discover Beam Therapeutics's headquarters at 238 Main St, Cambridge, MA 02142. Base editing therapeutics developer. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
0 min read
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min read$205M
Biotech
Kailera Therapeutics

Kailera Therapeutics raises $400M Series A at $1.5B valuation

Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...

Editorial Team
Oct 1, 2024
0 min read$400M
Side 1

Viser 9 rapporter • Side 1 • Kategori: all

Hold dig foran markedet

Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.